Your browser doesn't support javascript.
COVID-19 and Cancer: A Review of the Registry-Based Pandemic Response.
Desai, Aakash; Mohammed, Turab J; Duma, Narjust; Garassino, Marina C; Hicks, Lisa K; Kuderer, Nicole M; Lyman, Gary H; Mishra, Sanjay; Pinato, David J; Rini, Brian I; Peters, Solange; Warner, Jeremy L; Whisenant, Jennifer G; Wood, William A; Thompson, Michael A.
  • Desai A; Division of Medical Oncology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
  • Mohammed TJ; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
  • Duma N; Department of Medicine, University of Connecticut, Farmington.
  • Garassino MC; Division of Hematology, Department of Medicine, Medical Oncology and Palliative Care, University of Wisconsin, Madison.
  • Hicks LK; Department of Medicine, University of Chicago, Chicago, Illinois.
  • Kuderer NM; Division of Hematology/Oncology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Lyman GH; Advanced Cancer Research Group, Seattle, Washington.
  • Mishra S; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Pinato DJ; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Rini BI; Division of Oncology, Department of Medicine, University of Washington, Seattle.
  • Peters S; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Warner JL; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
  • Whisenant JG; Division of Oncology, Department of Translational Medicine, Piemonte Orientale University, Novara, Italy.
  • Wood WA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Thompson MA; Oncology Department, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
JAMA Oncol ; 7(12): 1882-1890, 2021 12 01.
Article in English | MEDLINE | ID: covidwho-1391526
ABSTRACT
Importance The COVID-19 pandemic has had consequences for patients with cancer worldwide and has been associated with delays in diagnosis, interruption of treatment and follow-up care, and increases in overall infection rates and premature mortality. Observations Despite the challenges experienced during the pandemic, the global oncology community has responded with an unprecedented level of investigation, collaboration, and technological innovation through the rapid development of COVID-19 registries that have allowed an increased understanding of the natural history, risk factors, and outcomes of patients with cancer who are diagnosed with COVID-19. This review describes 14 major registries comprising more than 28 500 patients with cancer and COVID-19; these ongoing registry efforts have provided an improved understanding of the impact and outcomes of COVID-19 among patients with cancer. Conclusions and Relevance An initiative is needed to promote active collaboration between different registries to improve the quality and consistency of information. Well-designed prospective and randomized clinical trials are needed to collect high-level evidence to guide long-term epidemiologic, behavioral, and clinical decision-making for this and future pandemics.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Registries / Pandemics / COVID-19 / Neoplasms Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: JAMA Oncol Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Registries / Pandemics / COVID-19 / Neoplasms Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: JAMA Oncol Year: 2021 Document Type: Article